SPRC logo

SPRC SciSparc Ltd.

NASDAQ Capital Market · Biotechnology · Healthcare

$0.35
-0.00 (-0.62%)

SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address …

Market Cap: $205.1Kscisparc.com

Price

No data yet.

Social Signal Score

31
5d
—
30d
—
60d
28
4 mentions
—
90d
35
11 mentions
—
news: 11

Revenue

$284.0K
$0.00$657.3K$1.31M$1.97M
Jun 2012Jun 2026

Analyst Estimates

FY2025
$0.03
$0.03–$0.03
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Oz Adler
Sector
Healthcare
Industry
Biotechnology
Employees
3
Beta
2.66
Country
IL
Piotroski score
3 / 9 (Weak)
Altman Z-score
-7.80
scisparc.com